齐勒贝西兰:一个有前途的抗高血压疗法,可以抑制 ангиотензиноген合成
Rida S Khan1, William H Frishman
1From the Department of Medicine, New York Medical College, Valhalla, NY.
Cardiology in review
|February 22, 2024
概括
齐勒贝西兰是一种新的siRNA疗法,通过沉默AGT基因,有效降低血压. 早期的试验显示持续降低血压,并为高血压管理提供了有利的安全性.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 系统性高血压影响全球超过10亿人,尽管有治疗方法,但控制率低于最佳水平.
- 新的治疗策略对于有效的血压管理至关重要.
- 氨酸- ангиотензин- алдостерон系统 (RAAS) 是抗高血压疗法的关键标.
研究的目的:
- 为了评估zilebesiran的疗效和安全性,一种新型的siRNA向血管新生素 (AGT) 生产.
- 评估zilebesiran对血压和血清AGT水平的剂量依赖性影响.
- 探索基因沉默作为高血压治疗方法的潜力.
主要方法:
- 齐勒贝西兰是一种siRNA,被皮下注射,以在转录后使肝脏中的AGT基因沉默.
- 进行了I期临床试验,以评估安全性,耐受性和药理动力学.
- 测量了对血压和血清 ангиотензиноген的剂量依赖作用.
主要成果:
- 观察到与剂量相关的血压降低和血清 ангиотензиноген水平.
- 在给药后的6个月内,Zilebesiran的持续作用被观察到.
- 安全性概况是有希望的,大多数不良事件是轻度至中度的.
结论:
- 齐勒贝西兰通过抑制RAAS在血管酶原水平上显示出作为一种新型抗高血压疗法的潜力.
- 该药物具有良好的安全性和持续的疗效,需要进一步研究.
- 目前正在进行二期试验,以确认疗效并确定高血压治疗的最佳剂量.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
638
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
638
Antihypertensive Drugs: Direct Renin Inhibitors
629
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
629
Antihypertensive Drugs: Angiotensin II Receptor Blockers
731
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
731
Antihypertensive Drugs: Thiazide-Class Diuretics
635
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
635
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
Antihypertensive Drugs: Potassium-Sparing Diuretics
554
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
554


